Related stories
J&J May Buy Ollin Biosciences for Up to $3.4 Billion, FT Reports
Johnson & Johnson could announce a deal as soon as Monday, the Financial Times reported, citing people familiar with the matter.
M impact | MNA | Nov 16, 2026, 12:46 AM UTC
FT: J&J Looks to Buy Ollin Biosciences for Up to $3.4 Billion
The Financial Times reported that Johnson & Johnson is looking to buy Ollin Biosciences for up to $3.4 billion.
M impact | MNA | Nov 16, 2026, 12:45 AM UTC
Canaccord Agrees to Sell UK Wealth Unit for $1.55 Billion
Canaccord Genuity agreed to sell its British wealth management business at an enterprise value of about £1.17 billion ($1.55 billion). CEO Dan Daviau is moving to take the remainin
M impact | MNA | Nov 16, 2026, 12:20 AM UTC
J&J Could Pay Ollin’s Backers $2.2 Billion Upfront
Under the deal, J&J could pay Ollin’s backers $2.2 billion upfront in cash, plus $1.2 billion in potential milestone payments.
M impact | MNA | Nov 16, 2026, 12:11 AM UTC
Johnson & Johnson Is Looking to Buy Ollin Biosciences for Up to $3.4 Billion
The Financial Times reported that Johnson & Johnson is looking to acquire Ollin Biosciences for up to $3.4 billion.
M impact | MNA | Nov 16, 2026, 12:11 AM UTC
Johnson & Johnson Looking to Buy Ollin Biosciences for Up to $3.4 Billion
M impact | MNA | Nov 16, 2026, 12:04 AM UTC